4893 items matching your search terms.

Review: computed tomographic colonography is accurate for medium and large colorectal polyps and cancer

Solomon, MJ Lord, SJ Walleser, S

Why should statins prevent venous thromboembolism? A systematic literature search and a call for action

Squizzato, A. Romualdi, E. Ageno, W.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006     DOI:10.1111/j.1538-7836.2006.02030.x

A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity

Steinbeck, KS Baur, LA Morris, AM Ghersi, D

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study

Stocker, R Pollicino, C Gay, CA Nestel, P Colquhoun, D Whiting, M Tonkin, A Sullivan, D Simes, J

The time taken to complete quality of life questionnaires in an advanced cancer trial

Stockler, MR Heritier, S Nowak, AK Goldstein, D Turner, J Jeord, M Glasgow, A Abdi, E Beale, PJ Carter, C

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

Stockler, MR Tattersall, MH Boyer, MJ Clarke, SJ Beale, PJ Simes, RJ

A placebo-controlled trial of sertraline’s effects on symptoms, well-being and survival in advanced cancer: the ZEST trial

Stockler, MR; O'Connell, R; Nowak, AK; Goldstein, D; Turner, J; Wilcken, NRC; Wyld, D; Abdi, E; Glasgow, A; Beale, PJ; Jefford, M; Dhillon, H; Heritier, S; Carter, C; Hickie, IB; Simes, RJ

A randomized trial of capecitabine given intermittently versus continuously versus classical CMF as first line chemotherapy for women with advanced breast cancer unsuited to more intensive treatment

Stockler, MR; Sourjina, T; Harvey, V; Frances, P; Byrne, M; van Hazel, G; Fitzharris, B; Ackland, S; Finch, K; Lindsay, D; Kato-Fong, A; Paksec, L; Gebski, V; Simes, RJ; Coates, AS; Forbes, J

Individual and combined effects of fenofibrate and sulphonylureas on HDL cholesterol and outcomes

Sullivan, D; Forder, P; Simes, J; Whiting, M; Keech, A; for the FIELD study investigators,

Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer

Tebbutt, N Gebski, V Strickland, A Gibbs, D Walpole, E Ganju, V Goldstein, D Munro, S Harrod, M Van Hazel, G

Predictors of survival benefits needed by pre-menopausal early breast cancer patients to make endocrine therapy worthwhile

Thewes, B. Meiser, B. Duric, V. M. Stockler, M. Stuart-Harris, R.

Letter regarding article by Tonelli et al, “Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease” [letter]

Tonelli, M; Isles, C; Craven, T; Furberg, C; Tonkin, A; Pfeffer, MA; Shepherd, J; Cobbe, SM; Sacks, FM; Simes, J; West, M; Packard, C; Curhan, GC

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study

Tonkin, AM Eckermann, S White, H Friedlander, D Glasziou, P Magnus, P Kirby, A Mulray, S Denton, M Sallaberger, M Hunt, D Simes, J on behalf of the LIPID Study Investigators,

The MAX study: MAXimising a clinical trial

Tunney, V Munro, SC Tebbutt, N Price, T Wilson, K

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)

Van Glabbeke, M; Verweij, J; Casali, PG; Simes, J; Cesne, AL; Reichardt, P; Issels, R; Judson, IR; Van Oosterom, AT; Blay, JY